{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Abelmoschus esculentus", "Blood glucose", "Diabetes", "Inflammation", "Lipid profiles", "Medicinal plants"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37507536", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "24"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1007/s00592-023-02149-1"], "Journal": {"ISSN": "1432-5233", "JournalIssue": {"Volume": "60", "Issue": "12", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Acta diabetologica", "ISOAbbreviation": "Acta Diabetol"}, "ArticleTitle": "Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial.", "Pagination": {"StartPage": "1685", "EndPage": "1695", "MedlinePgn": "1685-1695"}, "Abstract": {"AbstractText": ["The recent trend toward the use of natural functional and medical supplements has motivated the focus on the search and revival of traditional medicinal plant applications for many years. As a valuable dietary crop, okra fruit (Abelmoschus esculentus (L.) Moench) has been used for thousands of years as a medicinal food. This clinical trial aimed to assess the efficacy and safety of the okra pod capsule as an adjuvant treatment in controlling type 2 diabetes mellitus and provide clinical trial-based evidence about its anti-inflammatory effects.", "A total of 100 type II diabetic patients, aged between 40 and 60 years, were randomly assigned into two groups of okra and placebo. The first group was administered 1000 mg of powdered okra fruit three times a day for 3 months, while the other group received a placebo capsule with the same dosage. Both groups continued the standard antidiabetic therapy (consisting of metformin and gliclazide, as well as a nutritional regimen). At the start and three months later, various factors were measured, including FBG, insulin, HbA<sub>1c</sub>, cholesterol, triglycerides, HDL, LDL, CRP, liver and renal function tests, blood pressure, and BMI changes.", "According to the results, patients who received okra treatment exhibited a significant decrease in FBG, HbA<sub>1c</sub>, total cholesterol, and triglyceride levels when compared to both the baseline and the placebo group. Patients in the okra group have lower levels of hs-CRP compared with the placebo group after 3 months of treatment. No liver, kidney, and blood pressure or other side effects were observed in the groups associated with okra treatment.", "The present study demonstrated that adjunctive consumption of okra, in type 2 diabetic patients with 1000 mg three times a day for three months, improves lipid profile, glycemic control, and chronic inflammation without any tangible adverse effects.", "IRCT.Ir (IRCT20120112008712N2). https://www.irct.ir/trial/42042 ."], "CopyrightInformation": "\u00a9 2023. Springer-Verlag Italia S.r.l., part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran."}], "LastName": "Tavakolizadeh", "ForeName": "Mahdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran."}], "LastName": "Peyrovi", "ForeName": "Saeid", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ghasemi-Moghaddam", "ForeName": "Hussein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Microbiology, Sarab Faculty of Medical Sciences, Sarab, Iran."}], "LastName": "Bahadori", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agriculture and Plant Breeding, Agriculture Institute, Research Institute of Zabol, Zabol, Iran."}], "LastName": "Mohkami", "ForeName": "Zeynab", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran."}], "LastName": "Sotoudeh", "ForeName": "Mahtab", "Initials": "M"}, {"Identifier": ["0000-0002-9725-3033"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran. ziaee.m@mrgums.ac.ir."}], "LastName": "Ziaee", "ForeName": "Mojtaba", "Initials": "M"}], "GrantList": [{"GrantID": "68504", "Agency": "Maragheh University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Randomized Controlled Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Acta Diabetol", "NlmUniqueID": "9200299", "ISSNLinking": "0940-5429"}, "ChemicalList": [{"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}], "CommentsCorrectionsList": [{"RefSource": "Acta Diabetol. 2023 Dec;60(12):1697. doi: 10.1007/s00592-023-02170-4", "PMID": "37632536"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Abelmoschus"}, {"QualifierName": [], "DescriptorName": "Cholesterol"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Saeedi P, Petersohn I, Salpea P, et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. J Diabetes Res 157: 107843. https://doi.org/10.1016/j.diabres.2019.107843"}, {"Citation": "Tavakoly R, Maracy MR, Karimifar M, Entezari MH (2018) Does fenugreek (Trigonella foenum-graecum) seed improve inflammation, and oxidative stress in patients with type 2 diabetes mellitus? A parallel group randomized clinical trial. Eur J Integr Med 18:13\u201317", "ArticleIdList": ["10.1016/j.eujim.2018.01.005"]}, {"Citation": "Goldenberg JZ, Day A, Brinkworth GD, et al. (2021) Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 372"}, {"Citation": "Wu H, Ballantyne CM (2020) Metabolic inflammation and insulin resistance in obesity. Circ Res 126(11):1549\u20131564", "ArticleIdList": ["10.1161/CIRCRESAHA.119.315896", "32437299", "7250139"]}, {"Citation": "Al Hroob AM, Abukhalil MH, Alghonmeen RD, Mahmoud AM (2018) Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy. Biomed Pharmacother 106:381\u2013389. https://doi.org/10.1016/j.biopha.2018.06.148", "ArticleIdList": ["10.1016/j.biopha.2018.06.148", "29966984"]}, {"Citation": "Gora IM, Ciechanowska A, Ladyzynski P (2021) NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes. Cells 10(2):314", "ArticleIdList": ["10.3390/cells10020314", "33546399", "7913585"]}, {"Citation": "Asadi A, Shidfar F, Safari M, et al (2019) Efficacy of Melissa officinalis L. (lemon balm) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a randomized, double\u2010blind, clinical trial. Phytother Res 33(3):651\u2013659. https://doi.org/10.1002/ptr.6254"}, {"Citation": "Momtaz S, Salek-Maghsoudi A, Abdolghaffari AH et al (2019) Polyphenols targeting diabetes via the AMP-activated protein kinase pathway; future approach to drug discovery. Crit Rev Clin Lab Sci 56(7):472\u2013492", "ArticleIdList": ["10.1080/10408363.2019.1648376", "31418340"]}, {"Citation": "Unuofin JO, Lebelo SL (2020) Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: an updated review. Oxidative medicine and cellular longevity 2020"}, {"Citation": "Mokgalaboni K, Lebelo SL, Modjadji P, Ghaffary S (2023) Okra ameliorates hyperglycaemia in pre-diabetic and type 2 diabetic patients: a systematic review and meta-analysis of the clinical evidence. Front Pharmacol 14"}, {"Citation": "Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, Meshkani R (2018) The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetol 55:341\u2013353", "ArticleIdList": ["10.1007/s00592-017-1098-3", "29357033"]}, {"Citation": "Peter EL, Nagendrappa PB, Ajayi CO, Sesaazi CD (2021) Total polyphenols and antihyperglycemic activity of aqueous fruits extract of Abelmoschus esculentus: modeling and optimization of extraction conditions. PLoS ONE 16(4):e0250405", "ArticleIdList": ["10.1371/journal.pone.0250405", "33861803", "8051779"]}, {"Citation": "Sereno AB, Pinto CD, Andrade FA, et al (2022) Effects of okra (Abelmoschus esculentus (L.) Moench) on glycemic markers in animal models of diabetes: a systematic review. J Ethnopharmacol 115544. https://doi.org/10.1016/j.jep.2022.115544"}, {"Citation": "Elkhalifa AEO, Alshammari E, Adnan M et al (2021) Okra (Abelmoschus esculentus) as a potential dietary medicine with nutraceutical importance for sustainable health applications. Molecules 26(3):696. https://doi.org/10.3390/molecules26030696", "ArticleIdList": ["10.3390/molecules26030696", "33525745", "7865958"]}, {"Citation": "Esmaeilzadeh D, Razavi BM, Hosseinzadeh H (2020) Effect of Abelmoschus esculentus (okra) on metabolic syndrome: a review. Phytother Res 34(9):2192\u20132202. https://doi.org/10.1002/ptr.6679", "ArticleIdList": ["10.1002/ptr.6679", "32222004"]}, {"Citation": "Islam MT (2019) Phytochemical information and pharmacological activities of Okra (Abelmoschus esculentus): a literature-based review. Phytother Res 33(1):72\u201380", "ArticleIdList": ["10.1002/ptr.6212", "30346086"]}, {"Citation": "Lee T, Joo N (2021) Anti-inflammatory and antioxidant properties of ethanol extracts of raw, blanched, steamed, and sous-vide cooked okra (Abelmoschus esculentus L.) in LPS or H<sub>2</sub>O<sub>2</sub>-treated RAW264. 7 cells. Appl Sci 11(5): 2432"}, {"Citation": "Lim T, Lim T (2012) Abelmoschus esculentus. Edible Medicinal Non Med Plants: Volume 3, Fruits, 160\u2013167"}, {"Citation": "Huang C-N, Wang C-J, Lin C-L, Lin H-T, Peng C-H (2017) The nutraceutical benefits of subfractions of Abelmoschus esculentus in treating type 2 diabetes mellitus. PloS one 12(12): e0189065. https://doi.org/10.1371/journal.pone.0189065"}, {"Citation": "Peng C-H, Lin H-C, Lin C-L, Wang C-J, Huang C-N (2019) Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats. J Food Drug Anal 27(1):135\u2013144. https://doi.org/10.1016/j.jfda.2018.07.004", "ArticleIdList": ["10.1016/j.jfda.2018.07.004", "30648566"]}, {"Citation": "Moradi A, Tarrahi MJ, Ghasempour S, Shafiepour M, Clark CC, Safavi SM (2020) The effect of okra (Abelmoschus esculentus) on lipid profiles and glycemic indices in type 2 diabetic adults: randomized double blinded trials. Phytother Res 34(12):3325\u20133332. https://doi.org/10.1002/ptr.6782", "ArticleIdList": ["10.1002/ptr.6782", "32706159"]}, {"Citation": "Saatchi A, Aghamohammadzadeh N, Beheshtirouy S, Javadzadeh Y, Afshar FH, Ghaffary S (2022) Anti-hyperglycemic effect of Abelmoschus culentesus (Okra) on patients with diabetes type 2: a randomized clinical trial. Phytother Res 36(4):1644\u20131651. https://doi.org/10.1002/ptr.7341", "ArticleIdList": ["10.1002/ptr.7341", "35434945"]}, {"Citation": "Khodija U, Wiboworini B, Kartikasari L (2020) Comparing the effect of steamed and boiled okra (Abelmoschus esculentus) on fasting blood glucose among type 2 diabetes mellitus patients with hypercholesterolemia. Int J Nutr Sci 5(2):65\u201371"}, {"Citation": "Association AD (2021) 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142021. Diabetes Care 44(Supplement 1): S15-S33"}, {"Citation": "Sarbini D, Huriyati E, Sadewa H, Wahyuningsih MSH (2019) The effect of rosella (Hibiscus sabdariffa linn) on insulin resistance in patients with type 2 diabetes mellitus: a randomized clinical trial"}, {"Citation": "Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N (2019) The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Sci Rep 9(1):1\u201311. https://doi.org/10.1038/s41598-019-43838-8", "ArticleIdList": ["10.1038/s41598-019-43838-8"]}, {"Citation": "Group UPDS (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131):837\u2013853", "ArticleIdList": ["10.1016/S0140-6736(98)07019-6"]}, {"Citation": "Yaradua I, Ibrahim M, Matazu K et al (2017) Antidiabetic activity of Abelmoschus esculentus (Ex-Maradi Okra) fruit in alloxan-induced diabetic rats. Niger J Biochem Mol Biol 32:44\u201352"}, {"Citation": "Wu T, Rayner CK, Jones KL, Xie C, Marathe C, Horowitz M (2020) Role of intestinal glucose absorption in glucose tolerance. Curr Opin Pharmacol 55:116\u2013124", "ArticleIdList": ["10.1016/j.coph.2020.10.017", "33227625"]}, {"Citation": "Dantas TL, Alonso Buriti FC, Florentino ER (2021) Okra (Abelmoschus esculentus L.) as a potential functional food source of mucilage and bioactive compounds with technological applications and health benefits. Plants 10(8):1683. https://doi.org/10.3390/plants10081683"}, {"Citation": "Fan S, Zhang Y, Sun Q et al (2014) Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL/6 mice. J Nutr Biochem 25(7):702\u2013709", "ArticleIdList": ["10.1016/j.jnutbio.2014.02.010", "24746837"]}, {"Citation": "Nikpayam O, Safaei E, Bahreini N, Saghafi-Asl M (2021) The effects of okra (Abelmoschus esculentus L.) products on glycemic control and lipid profile: a comprehensive systematic review. J Funct Foods 87: 104795. https://doi.org/10.1016/j.jff.2021.104795"}, {"Citation": "Wengrofsky P, Lee J, Makaryus AN (2019) Dyslipidemia and its role in the pathogenesis of atherosclerotic cardiovascular disease: implications for evaluation and targets for treatment of dyslipidemia based on recent guidelines. In: Dyslipidemia. IntechOpen"}, {"Citation": "Dludla PV, Nkambule BB, Nyambuya TM et al (2022) Vitamin C intake potentially lowers total cholesterol to improve endothelial function in diabetic patients at increased risk of cardiovascular disease: a systematic review of randomized controlled trials. Front Nutr 9:2524", "ArticleIdList": ["10.3389/fnut.2022.1011002"]}, {"Citation": "Garjani A, Andalib S, Ziaee M, Maleki-Dizaji N (2008) Biphasic effects of atorvastatin on inflammation. Pak J Pharm Sci 21(2):125\u2013130", "ArticleIdList": ["18390442"]}, {"Citation": "Ngoc TH, Ngoc QN, Tran A, Phung NV (2008) Hypolipidemic effect of extracts from Abelmoschus esculentus L. (Malvaceae) on tyloxapol-induced hyperlipidemia in mice. Mahidol Univ J Pharm Sci 35(1\u20134): 42\u201346"}, {"Citation": "Majd NE, Tabandeh MR, Shahriari A, Soleimani Z (2018) Okra (Abelmoscus esculentus) improved islets structure, and down-regulated PPARs gene expression in pancreas of high-fat diet and streptozotocin-induced diabetic rats. Cell J (Yakhteh) 20(1):31. https://doi.org/10.22074/cellj.2018.4819"}, {"Citation": "Wu J, Shi S, Wang H, Wang S (2016) Mechanisms underlying the effect of polysaccharides in the treatment of type 2 diabetes: a review. Carbohydr Polym 144:474\u2013494", "ArticleIdList": ["10.1016/j.carbpol.2016.02.040", "27083840"]}, {"Citation": "Ziaee M, Mashayekhi S, Ghaffari S, Mahmoudi J, Sarbakhsh P, Garjani A (2019) Predictive value of endocan based on TIMI risk score on major adverse cardiovascular events after acute coronary syndrome. Angiology 70(10):952\u2013959", "ArticleIdList": ["10.1177/0003319718815241", "30514091"]}, {"Citation": "Kanmani S, Kwon M, Shin M-K, Kim MK (2019) Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study. Sci Rep 9(1):4573", "ArticleIdList": ["10.1038/s41598-019-40987-8", "30872696", "6418102"]}, {"Citation": "Bilgin S, Kurtkulagi O, Tel BMA et al (2021) Does C-reactive protein to serum albumin ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study. Prim Care Diabetes 15(6):1071\u20131074", "ArticleIdList": ["10.1016/j.pcd.2021.08.015", "34497035"]}, {"Citation": "Mahdavi AM, Javadivala Z, Ahmadian E (2022) Effects of Okra (Abelmoschus esculentus L.) on inflammatory mediators: a systematic review of preclinical studies. Food Funct"}, {"Citation": "Liu Y, Qi J, Luo J et al (2021) Okra in food field: nutritional value, health benefits and effects of processing methods on quality. Food Rev Intl 37(1):67\u201390", "ArticleIdList": ["10.1080/87559129.2019.1695833"]}, {"Citation": "Xiong B, Zhang W, Wu Z et al (2021) Preparation, characterization, antioxidant and anti-inflammatory activities of acid-soluble pectin from okra (Abelmoschus esculentus L.). Int J Biol Macromol 181:824\u2013834", "ArticleIdList": ["10.1016/j.ijbiomac.2021.03.202", "33836194"]}, {"Citation": "Liu Y, Ye Y, Hu X, Wang J (2021) Structural characterization and anti-inflammatory activity of a polysaccharide from the lignified okra. Carbohydr Polym 265:118081", "ArticleIdList": ["10.1016/j.carbpol.2021.118081", "33966845"]}, {"Citation": "Nasrollahi Z, ShahaniPour K, Monajemi R, Ahadi AM (2022) Abelmoschus esculentus (L.) Moench improved blood glucose, lipid, and down\u2010regulated PPAR\u2010\u03b1, PTP1B genes expression in diabetic rats. J Food Biochem 46(7):e14097"}, {"Citation": "Li Y (2017) Hypoglycemic effect of okra extract on type 2 diabetic mice and correlation with TNF-\u03b1 and IDE. Chin Trad Herbal Drugs, 3131\u20133137"}, {"Citation": "Tyagita N, Utami K, Zulkarnain F et al (2019) Okra infusion water improving stress oxidative and inflammatory markers on hyperglycemic rats. Bangladesh J Med Sci 18(4):748\u2013752. https://doi.org/10.3329/bjms.v18i4.42879", "ArticleIdList": ["10.3329/bjms.v18i4.42879"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "21"}, {"Year": "2023", "Month": "6", "Day": "27"}, {"Year": "2023", "Month": "10", "Day": "23", "Hour": "12", "Minute": "46"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "28", "Hour": "23", "Minute": "27"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37507536", "10.1007/s00592-023-02149-1", "10.1007/s00592-023-02149-1"]}}], "PubmedBookArticle": []}